CVS Health Corporation’s Stock Price Soars to $61.38, Showcasing a Strong 4.02% Uptick

CVS Health Corporation (CVS)

61.38 USD +2.37 (+4.02%) Volume: 12.51M

CVS Health Corporation’s stock price surged by 4.02% this trading session, closing at 61.38 USD, with a trading volume of 12.51M. Despite the recent rise, the stock is still down by 22.26% year-to-date, reflecting a turbulent year for CVS shareholders.

Latest developments on CVS Health Corporation

Today, CVS Health Corp (CVS) stock price saw a significant increase of 4.36%, catching the attention of investors. This rise comes amidst bullish sentiments from hedge funds towards the health insurance company. Additionally, CVS Health has been actively supporting customers, patients, members, and colleagues as Hurricane Helene approaches, showcasing its commitment to community well-being. Meanwhile, Evergreen Capital Management LLC recently sold a large number of CVS Health Co. shares. These events have contributed to the fluctuation in CVS Health Corp stock price today.

CVS Health Corporation on Smartkarma

Analysts at Baptista Research on Smartkarma have been closely monitoring Cvs Health Corp‘s performance, providing valuable insights for investors. In a report titled “CVS Health Corporation: Strategic Leverage in Pharmacy Benefit Management (PBM) and Insurance Operations! – Major Drivers,” the analysts highlighted the company’s mixed financial results in the second quarter of 2024. Despite facing notable challenges, CVS Health delivered an adjusted earnings per share of $1.83 and saw revenues exceeding $91 billion, supported by strong performance in the Health Services and Pharmacy & Consumer Wellness segments.

Another report by Baptista Research, “CVS Health Corporation: Will The Increasing Margin in Medicare Advantage Last? – Major Drivers,” discussed the positive and negative impacts on CVS Health’s business structure in Q1 2024. The company reported lower-than-expected earnings per share of $1.31, attributed to significant utilization pressures in the Medicare Advantage, affecting its Health Care Benefits segment. As a result of these challenges, CVS Health revised its full-year guidance for adjusted EPS to at least $7, reflecting the analysts’ cautious outlook on the company’s performance.

A look at CVS Health Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on Smartkarma Smart Scores, CVS Health Corp has a positive long-term outlook. With top scores in both Value and Dividend, the company is seen as a strong investment option. While it has slightly lower scores in Growth, Resilience, and Momentum, CVS Health Corp’s overall outlook remains solid.

As an integrated pharmacy health care provider, CVS Health Corp offers a range of services including pharmacy benefit management, retail pharmacy, and disease management programs. With a strong presence in the U.S., the District of Columbia, and Puerto Rico, CVS Health Corp is well-positioned to continue providing essential health care services to its customers.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma